Report of the International Narcotics Control Board on the availability of internationally controlled drugs: ensuring adequate access for medical and scientific purposes.

摘要

The International Narcotics Control Board was invited by the Commission on Narcotic Drugs at its fifty-third session, in March 2010, to include in its report for 2010 information on the availability of internationally controlled substances for medical requirements. The Board is aware of the growing interest of the World Health Organization, other intergovernmental bodies and non-governmental organizations in this matter. In recognition of its importance, the Board has decided to devote audsupplement to its annual report to this subject. ududThis format allows the Board to provide adequate information on the present situation, globally and regionally, to highlight major impediments and to formulate recommendations to improve the availability of internationally controlled substances for medical and scientific purposes. A detailed analysis is contained in the Board’s technical publications on narcotic drugs and psychotropic substances.ududContents:udChapter I. IntroductionudChapter II. Action taken by the Board to ensure adequate availabilityudChapter III. Supply of opiate raw materials and opioidsudChapter IV. Availability of medicines containing internationally controlled substancesudChapter V. Achieving a balance between ensuring availability of internationally controlled substances for medical and scientific purposes and preventing their diversion and abuseudChapter VI. Conclusions and recommendationsudAnnexes:udI. Tables on consumption of opioid analgesics in regionsudII. Joint letter from the President of the International Narcotics Control Board and the Chair of the United Nations Development GroupudIII. Follow-up joint letter from the President of the International Narcotics Control Board and the Chair of the United Nations Development GroupudIV. Letter from the President of the International Narcotics Control Board to all countries